Choriocapillaris Changes Imaged by OCT Angiography After Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:23
|
作者
Fujita, Kyoko [1 ]
Kawamura, Akiyuki [2 ]
Yuzawa, Mitsuko [2 ]
机构
[1] Kansai Med Univ, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan
[2] Nihon Univ, Chiyoda Ku, Tokyo, Japan
来源
关键词
INDOCYANINE GREEN ANGIOGRAPHY; VERTEPORFIN; LEVEL;
D O I
10.3928/23258160-20170329-04
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BACKGROUND AND OBJECTIVE: To evaluate the choriocapillaris using optical coherence tomographic angiography (OCTA) after half-dose verteporfin photodynamic therapy (hd-PDT) for chronic central serous chorioretinopathy (CSC). PATIENTS AND METHODS: We studied six eyes (six patients) with chronic CSC treated by hd-PDT. OCTA was performed before, 1 week after, and 1 month after hd-PDT. The area of flow abnormality at the choriocapillaris level within the PDT spot after hd-PDT was compared with that before hd-PDT. RESULTS: Serous retinal detachment was diminished in all eyes, with three achieving complete resolution at 1 month. On OCTA, all eyes showed irregular choriocapillaris flow before hd-PDT. The areas of abnormal flow shrank progressively at 1 month after hd-PDT. CONCLUSION: On OCTA, choriocapillaris flow tended to recover at 1 month after hd-PDT. OCTA may be clinically useful for evaluating choriocapillaris and the therapeutic effects of hd-PDT for chronic CSC.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 50 条
  • [21] Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Cheng, Zhihang
    Babiker, Salma
    Lenfestey, Pauline
    Beare, Nick
    Pearce, Ian A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [22] Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
    R Uetani
    Y Ito
    K Oiwa
    K Ishikawa
    H Terasaki
    Eye, 2012, 26 : 640 - 649
  • [23] Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
    Tseng, Chien-Chi
    Chen, San-Ni
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (08) : 1070 - 1077
  • [24] Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
    Uetani, R.
    Ito, Y.
    Oiwa, K.
    Ishikawa, K.
    Terasaki, H.
    EYE, 2012, 26 (05) : 641 - 648
  • [25] Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy
    Liu, Hsin-Yu
    Yang, Chang-Hao
    Yang, Chung-May
    Ho, Tzyy-Chang
    Lin, Chang-Ping
    Hsieh, Yi-Ting
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 167 : 57 - 64
  • [26] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Oiwa, Kazuhiro
    Kataoka, Keiko
    Maruko, Ruka
    Ueno, Shinji
    Ito, Yasuki
    Terasaki, Hiroko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (03) : 260 - 266
  • [27] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Kazuhiro Oiwa
    Keiko Kataoka
    Ruka Maruko
    Shinji Ueno
    Yasuki Ito
    Hiroko Terasaki
    Japanese Journal of Ophthalmology, 2017, 61 : 260 - 266
  • [28] The safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, H. M. A.
    Diederen, R. M. H.
    Lamme, M. J. C. M.
    Fauser, S.
    Downes, S. M.
    Schlingemann, R. O.
    Hoyng, C. B.
    van Dijk, E. H. C.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 19 - 19
  • [29] Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
    Etsuyo Horiguchi
    Jun Takeuchi
    Ryo Tomita
    Keiko Asai
    Yuyako Nakano
    Hikaru Ota
    Yosuke Taki
    Yasuki Ito
    Hiroko Terasaki
    Koji M. Nishiguchi
    Keiko Kataoka
    Scientific Reports, 12
  • [30] Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy
    Yang, Hyun Seung
    Kang, Tae Gu
    Park, Hyun
    Heo, Ji Su
    Park, Jonghoon
    Lee, Kyung Sub
    Choi, Sangkyung
    PLOS ONE, 2020, 15 (01):